MStranslate logo
Log In
Lost your password?
Lost Password
Back to login
Search
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us
Breaking
  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast - Episode Library
  • Patient Community Day at ECTRIMS 2025
  • Multiple Sclerosis in 2025 – Key Developments to Date
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us

Tagged multiple sclerosis

ECTRIMS 2019

ECTRIMS 2019: Final Thoughts From Stockholm

MStranslate
September 13, 2019
Dr Travis Stiles, ECTRIMS, Research
ECTRIMS 2019 has officially ended.  It is safe to say that it was a huge three days and I am exhausted!  I really hope that you have enjoyed the...
exercise training

Exercise Barriers in Multiple Sclerosis: Falling

MStranslate
April 4, 2019
Exercise, Lifestyle, Movement Disorders, Rehabilitation, Research, Symptoms
It won’t come as a surprise to many that research has shown regular exercise can be especially important for people living with multiple sclerosis....
food allergy

Food Allergies & Increased Disease Activity In MS

MStranslate
January 2, 2019
Basic Sciences, Diet, Lifestyle, Research
Recently, we featured a Facebook post that mentioned the results of two major US studies, including one that looked at the links between multiple...
asthma

Asthma More Common In People With MS

MStranslate
December 28, 2018
Basic Sciences, Research
1 Comment
Recently, we featured a Facebook post that mentioned the results of two major US studies, one of which looked at the links between multiple sclerosis...
heart disease

Heart Disease Linked To Brain Atrophy In MS

MStranslate
August 15, 2018
Basic Sciences, Lifestyle, Research
2 Comments
Research Summary:  Hypertension and heart disease are associated with development of brain atrophy in multiple sclerosis: a 5-year longitudinal...
primary progressive MS research

Primary Progressive MS Research: Treatment Outcomes

MStranslate
August 9, 2018
Progressive MS, Research, Treatments
PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS Primary progressive multiple sclerosis (PPMS) is characterised by a steady worsening of disease or...
blood platelets

Inflammation in the CNS is driven by platelets

MStranslate
July 31, 2018
Basic Sciences, Ocular Motor, Research
1 Comment
RESEARCH SUMMARY:  Platelets Drive Inflammation and Target Gray Matter and the Retina in Autoimmune-Mediated Encephalomyelitis. In this article, we...
myelin repair microglia

Myelin Repair: Cellular Switch Identified?

MStranslate
July 24, 2018
Basic Sciences, Progressive MS, Remyelination, Research
1 Comment
PROGRESSIVE MULTIPLE SCLEROSIS AND MYELIN REPAIR We have seen an increasing number of powerful new treatments developed recently for relapsing...
cause of multiple sclerosis theory

Cause of Multiple Sclerosis: Discovery or Theory?

MStranslate
July 23, 2018
Epstein-Barr virus, Infection, Research
CAUSE OF MULTIPLE SCLEROSIS DISCOVERED? Reports have started appearing online today, which claim that doctors from Harvard T.H Chan School of Public...
cannabis for chronic pain

Cannabis and Chronic Pain: Research Summary

MStranslate
July 19, 2018
Medicinal Cannabis, Research, Treatments
Research Summary: Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: findings from a 4-year prospective cohort...
  1. 1
  2. 2

Recent Posts

  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast – Episode Library
  • Patient Community Day at ECTRIMS 2025

Recent Comments

  • FDA Decision On Tolebrutinib - MStranslate on Multiple Sclerosis in 2025 – Key Developments to Date
  • Treatment With Gut Bacteria Shows Benefits In New Study on Gut Bacteria in People Living with RRMS
  • Community Q&A: COVID-19 Vaccines & Multiple Sclerosis on Community Q&A: The Blood-Brain Barrier
  • Community Q&A: Why Don't We Have A Multiple Sclerosis Cure? on Community Q&A: COVID-19 Vaccines & MS
  • Tim Little on FAKE NEWS ALERT: COVID Vaccines & MS

Calendar

March 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
« Jan    

Archives

Categories

Posts

  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast – Episode Library
  • Patient Community Day at ECTRIMS 2025

Google+

Get social

Copyright 2014-2018 MStranslate. All Rights Reserved. Contact Us
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.